US Bancorp DE decreased its stake in Centene Corporation (NYSE:CNC – Free Report) by 28.8% during the 3rd quarter, Holdings Channel reports. The firm owned 307,194 shares of the company’s stock after selling 124,447 shares during the quarter. US Bancorp DE’s holdings in Centene were worth $10,961,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CNC. WPG Advisers LLC grew its holdings in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares in the last quarter. Versant Capital Management Inc grew its stake in shares of Centene by 11.6% in the 3rd quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after buying an additional 355 shares during the period. Snowden Capital Advisors LLC increased its holdings in shares of Centene by 8.0% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock worth $275,000 after buying an additional 374 shares during the last quarter. MAI Capital Management lifted its holdings in Centene by 6.3% in the third quarter. MAI Capital Management now owns 6,545 shares of the company’s stock valued at $234,000 after acquiring an additional 388 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC raised its position in Centene by 54.9% in the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after purchasing an additional 390 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on CNC shares. Mizuho set a $47.00 price target on Centene in a report on Friday, January 9th. TD Cowen increased their target price on shares of Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday, February 11th. Argus raised shares of Centene to a “hold” rating in a research note on Monday, February 9th. Robert W. Baird increased their price objective on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Finally, Wall Street Zen downgraded shares of Centene from a “buy” rating to a “hold” rating in a report on Sunday, February 15th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, Centene currently has an average rating of “Hold” and a consensus target price of $42.00.
Centene Stock Performance
Shares of CNC opened at $44.82 on Friday. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The company’s 50 day simple moving average is $42.83 and its 200-day simple moving average is $37.56. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87. The firm has a market cap of $22.04 billion, a PE ratio of -3.29, a price-to-earnings-growth ratio of 1.00 and a beta of 0.48.
Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period last year, the firm earned $0.80 EPS. The company’s quarterly revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities analysts predict that Centene Corporation will post 6.86 EPS for the current year.
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
